Dr. Maayan Gal

Dr. Maayan Gal is a member of the Faculty of Medicine. He completed his Ph.D. studies at the Chemical Physics Department at the Weizmann Institute, focusing on developing new magnetic resonance methods for monitoring bimolecular events. He then continued as an HFSP postdoctoral fellow at Harvard Medical School, working on protein interactions aiming to decipher the structure-function relation of T-cell activation switch proteins, NFAT, and calcineurin. He then joined as a leading researcher to Migal-Galilee research institute, where he developed small molecule inhibitors for therapeutic and agricultural uses and established a new biotech startup company. The lab in TAU is focused on discovering and developing novel protein modulators as the basis for new therapeutics. The challenging targets of the biological space of protein-protein interactions (PPIs) are of primary interest.

Under the scope of regenerative medicine, the lab explores new ways to activate collagen stimulation and enhance bone regeneration. The study includes cutting-edge computational, biophysical, and cellular biology tools.